CAPTRUST Financial Advisors’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
CAPTRUST Financial Advisors's NVCT Position: Q3 2026 in Review
CAPTRUST Financial Advisors opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 10,507 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings.
95 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.
- CAPTRUST Financial Advisors held 10,507 shares of Nuvectis Pharma worth $222K as of Q3 2026.
- Nuvectis Pharma was a new CAPTRUST Financial Advisors position in Q3 2026.
- Nuvectis Pharma made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #2880 holding.
- 95 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.